Newsroom

latest news from ose
and across our portfolio

Featured News

Portfolio news – Oxford Ionics reaches agreement to be acquired by IonQ for $1.075 Billion
Portfolio news – Oxford Ionics reaches agreement to be acquired by IonQ for $1.075 Billion
Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsSpyBiotechSpyBiotech fortifies board with biotech veteran Stuart ChaffeePortfolio NewsSpyBiotechSpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical OfficerPortfolio NewsSpyBiotechSpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLO1 Targeting Human Cytomegalovirus (HCMV)Portfolio NewsSpyBiotechSpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of OxfordPortfolio NewsSpyBiotechSpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01Portfolio NewsSpyBiotechSpyBiotech Receives Grant from the Bill & Melinda Gates FoundationPortfolio NewsSpyBiotechSpybiotech appoints industry veteran Eddie Gray as Chair of its Board of DirectorsPortfolio NewsSpyBiotechSpyBiotech appoints seasoned biotech executive Mark Leuchtenberger as Chief Executive OfficerPortfolio NewsSpyBiotechStudies using SpyBiotech’s vaccine technology shows potential against Covid-19 and other coronavirusesPortfolio NewsSpyBiotechSpyBiotech announces the appointment of Simon Jones as VP, Finance and Operations and expansion of the scientific teamPortfolio NewsSpyBiotechSpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific AdvisorPortfolio NewsSpyBiotechSpyBiotech raises $32.5 million in Series A funding and appoints Lutz B. Giebel as Chairman